"Europe stands at a pivotal moment. On one hand, demographic pressures, energy market volatility and sluggish productivity are squeezing growth. On the other hand, the continent has an opportunity to reassert its competitiveness with the United States and China, which are taking the lead in strategic technologies such as AI. This matters because AI is arguably the most transformative technology for productivity in history."
"By one estimate, generative AI alone could add over $4 trillion to global GDP by 2030. Even a small slice of that pie could be game-changing for Europe's prosperity. European organizations do not need to take the lead in AI model development to benefit from the technology or revive their competitiveness. Instead, there is a generational opportunity to become the first to deeply embed AI at scale, harnessing the advantages of their unique enterprise data."
"Examples are showing up across industries. Consider a logistics operator that has embedded AI agents throughout its supply chain. These intelligent systems predict demand, reroute shipments, and optimize deliveries in real time, improving customer experience and margins. Or take a pharmaceutical company using AI to accelerate drug discovery by automating reviews of scientific literature and screening new molecules. What once took months now happens in days or hours, bringing treatments to market faster."
Europe faces demographic pressures, energy market volatility, and sluggish productivity that constrain growth. AI represents a transformative productivity technology with estimates suggesting generative AI could add over $4 trillion to global GDP by 2030. European organizations can gain by deeply embedding AI at scale using unique enterprise data without leading core model development. Rapid AI adoption combined with industrial strength, strong regulation, and world-class talent can create competitive differentiation and economic renewal. Real use cases are delivering results: logistics operators optimize supply chains in real time and pharmaceutical firms accelerate drug discovery. An IBM survey found 66% of senior European executives saw measurable productivity gains from AI, with 41% expecting ROI within a year.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]